Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India

PURPOSE: Biomarker—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) —discordance plays an essential role in the management and prognosis of patients with metastatic breast cancer. Rates of discordance have been previously reported around 12%...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Glob Oncol
Main Authors: Gogia, Ajay, Deo, S. V. Suryanarayana, Sharma, Dayanand, Phulia, Rakesh K., Thulkar, Sanjay, Malik, Prabhat S., Mathur, Sandeep
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6528736/
https://ncbi.nlm.nih.gov/pubmed/30951390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JGO.18.00184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados